Comments
Indian Institute of Chemical Technology (IICT) – CSIR has played a key role in developing Bharat Biotech’s Covid-19 vaccine, Covaxin.
Hyderabad-based IICT helped in the synthesis of Agonist molecules for use in Covaxin. It was approached by Bharat Biotech to develop the synthetic route for the agonist molecule with indigenous chemicals at an affordable price and with highest purity. This agonist molecule has aided in scaling up the production of the adjuvant, IICT said.
“The process technology developed by CSIR-IICT for the agonist molecule is playing an important role in the production of adjuvant for Covaxin,” said Shekhar Mande, DG, CSIR and Secretary, DSIR.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.